ANDA 91054, held by Aurobindo Pharma USA. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 91054 (Promethazine Hydrochloride), held by Aurobindo Pharma USA, was first approved by FDA on Aug 30, 2011, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 30, 2011 | Original application | Approved | None posted |
| Promethazine Hydrochloride12.5MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride25MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride50MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Jan 3, 2012 | Supplement 1Labeling | Approved | None posted |
| Aug 30, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters